Sukhmani K. Padda was named director of Thoracic Medical Oncology at Cedars-Sinai Cancer.
Padda’s research focuses on therapies for thoracic cancers, with a particular interest in improving treatment for genomic subsets of lung cancer, including KRAS- and EGFR-positive lung cancer, and rare thoracic tumors, such as thymic malignancies and lung neuroendocrine tumors.
She also studies questions related to tumor biomarkers to help determine the best treatments for patients.
